Congestive Heart Failure Readmission and Guideline Based Therapy Rates Improvement At Safety Net Hospital Heart Health Center
The 2017 HFSA co-sponsored guidelines on heart failure (HF) focus on developing strategies to lower readmission rates and increase adherence to guideline directed medical therapy (GDMT), specifically beta blockers (BB), ACE inhibitors and Angiotensin II receptor blockers (ACEi/ARB), spironolactone, Bidil or combined hydralazine/isosorbide dinitrate (Hydral/ISDN), and ARB with neprilysin inhibitor (ARNI). Patients with HF at a disproportionately elevated risk for readmission are those in median-low income, often minority populations, at public safety net hospitals.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Noah Silverstein, Perry Wengrofsky, Evan Botti, Filip Oleszak, Inna Bukharovich Tags: 338 Source Type: research
More News: Beta-Blockers | Cardiology | Congestive Heart Failure | Heart | Heart Failure | Hospitals | Hydralazine | Spironolactone